Headquarters: Paris, France

Founded: 1973

Employees: 95,442

CEO: Mr. Paul Hudson

Euronext: SAN -1.19%

Market Cap

€116.03 Billion

EUR as of Jan. 1, 2024

US$128.15 Billion

Market Cap History

Company Description

Sanofi, along with its subsidiaries, is involved in the research, development, manufacture, and marketing of various therapeutic solutions. It operates in three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. It offers a wide range of products for specialty care, diabetes, cardiovascular issues, and provides vaccines for various diseases, consumer healthcare products, wellness, probiotics, digestive, and nutritional products.

Sanofi market capitalization over time

Evolution of Sanofi market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Sanofi

Detailed Description

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Product & Services

Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)

Key People

Founder(s): Elf Aquitaine

Serge Weinberg (Chairman) Paul Hudson (CEO)


Revenue: €36.12 billion (2020)

Operating income: €15.50 billion (2020)

Net income: €12.35 billion (2020)

Total assets: €115.75 billion (2020)

Total equity: €60.10 billion (2020)



54, Rue La BoEtie

Paris, 75008


Phone: 33 1 53 77 40 00